Analysis Tools
immune system
|
• in untreated mice and mice treated with imiquimod-containing Aldara cream with an increase in IL17A expression
|
|
• in untreated mice and mice treated with imiquimod-containing Aldara cream
|
|
• of IL17+ cells in untreated mice without an increase after treatment with imiquimod-containing Aldara cream
|
|
• mice treated with imiquimod-containing Aldara cream exhibit increased CD4+ and gammadelta T cells expressing IL22 in the skin compared with wild-type mice
|
|
• in untreated mice and mice treated with imiquimod-containing Aldara cream
|
|
• in skin CD4+ T cells from mice treated with imiquimod-containing Aldara cream
|
|
• mice treated with imiquimod-containing Aldara cream exhibit increased frequency of CD11b+ cells in skin infiltrate compared with wild-type mice
• however, the composition of myeloid cellular infiltrates is normal
|
integument
|
• mice treated with imiquimod-containing Aldara cream exhibit increased frequency of CD11b+ cells in skin infiltrate compared with wild-type mice
• however, the composition of myeloid cellular infiltrates is normal
|
|
• mice treated with imiquimod-containing Aldara cream exhibit mild reduction of psoriasis-like disease (skin redness, epidermal hyperplasia, thickness and scaling) compared with wild-type mice
• however, the composition of myeloid cellular infiltrates is normal
|
hematopoietic system
|
• in untreated mice and mice treated with imiquimod-containing Aldara cream with an increase in IL17A expression
|
|
• in untreated mice and mice treated with imiquimod-containing Aldara cream
|
|
• of IL17+ cells in untreated mice without an increase after treatment with imiquimod-containing Aldara cream
|
